| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/18/1997 | WO1997047358A1 Synthetic hepatitis c genes |
| 12/18/1997 | WO1997047320A1 Immunstimulating lipid formulation |
| 12/18/1997 | WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | WO1997047271A2 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 12/18/1997 | WO1997047197A1 Compositions and methods for administering borrelia dna |
| 12/18/1997 | WO1997041823A3 MOLECULAR GENETIC CONSTRUCTION OF VACCINE STRAINS OF $i(PASTEURELLACEAE) |
| 12/18/1997 | WO1997035982A3 Monocyte chemotactic protein-5 materials and methods |
| 12/18/1997 | DE19724546A1 Composition for treating cancer, containing proteins and/or peptide(s) |
| 12/18/1997 | CA2258082A1 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 12/18/1997 | CA2258016A1 Compositions and methods for administering borrelia dna |
| 12/18/1997 | CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | CA2257861A1 Hexameric fusion proteins and uses therefor |
| 12/18/1997 | CA2257137A1 Synthetic hepatitis c genes |
| 12/18/1997 | CA2256710A1 Vaccine containing a peroxiredoxin and/or a .beta.-tubulin |
| 12/17/1997 | EP0812593A1 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a |
| 12/17/1997 | EP0812360A1 Human geranylgeranyl pyrophosphate synthetase |
| 12/17/1997 | EP0812359A1 Group o hiv-1, fragments of such viruses, and uses thereof |
| 12/17/1997 | EP0812358A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| 12/17/1997 | EP0812357A1 A method for making heteromultimeric polypeptides |
| 12/17/1997 | EP0812356A1 Prostate-specific membrane antigen and uses thereof |
| 12/17/1997 | EP0812333A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 12/17/1997 | EP0812332A1 AN IMMUNOINTERACTIVE MOLECULE WHICH BINDS THE $i(TIE)2/TEK RECEPTOR EXTRACELLULAR DOMAIN |
| 12/17/1997 | EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 12/17/1997 | EP0812213A1 Gel form of a vaccine |
| 12/17/1997 | EP0812212A1 Compositions for the delivery of antigens |
| 12/17/1997 | EP0812209A1 Cochleate phospholipids in drug delivery |
| 12/17/1997 | EP0812206A1 Method for stimulating an immune response |
| 12/17/1997 | EP0812191A1 Aglyco products |
| 12/17/1997 | EP0693132B1 Rapamycin assay |
| 12/17/1997 | EP0656789B1 Method for treating a lfa-1-mediated disorder |
| 12/17/1997 | EP0652896B1 Peptide compounds |
| 12/17/1997 | EP0612251B1 Stabilised antibodies |
| 12/17/1997 | EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 12/17/1997 | EP0557535B1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
| 12/17/1997 | EP0540599B1 Adoptive immunotherapy with interleukin-7 |
| 12/16/1997 | US5698763 Transgenic animals lacking prion proteins |
| 12/16/1997 | US5698679 Immunoglobulin fusion protein |
| 12/16/1997 | US5698531 Delivering a dna sequence encoding a therapeutic or diagnostic protein by catheterization to a discrete blood vessel segment using genetically engineered or normal cells or vector systems; drug delivery |
| 12/16/1997 | US5698530 A vaccinia virus into which carcinoembryonic antigen gene is inserteted; induce an active immune response |
| 12/16/1997 | US5698520 Peptide related to human programmed cell death and DNA encoding the same |
| 12/16/1997 | US5698439 Novel malignant cell type markers of the interior nuclear matrix |
| 12/16/1997 | US5698438 Bacterial hemoglobin receptor gene |
| 12/16/1997 | US5698433 Infecting the cell of culture with inflenza virus; adding protease |
| 12/16/1997 | US5698432 Producing inactivated whole virus by treating with general inactivating agent, deaggregating agent, nucleic acid inactivating agent, then stabilizing with crosslinking agent |
| 12/16/1997 | US5698431 Deficient in virion host shutoff function, profoundly attenuated in its ability to replicate at periphery and in the nervous system, and reactivate from latency |
| 12/16/1997 | US5698430 Non-infective vaccines |
| 12/16/1997 | US5698424 Capsid forming and cystein modified chimaeric MS2-coat protein |
| 12/16/1997 | US5698419 Formed by fusion of cells from mouse myeloma line and spleen cells from mouse previously immunized with cachectin-tumor necrosis factor |
| 12/16/1997 | US5698416 Dna sequence encoding proteins |
| 12/16/1997 | US5698405 Coupling immunogenic agent with a carbohydrate polymer |
| 12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
| 12/16/1997 | US5698390 Incubating sample including hepatitis c polypeptide that binds to antibody under conditions that allow for formation of antibody-antigen complex |
| 12/16/1997 | US5698271 Methods for the manufacture of magnetically responsive particles |
| 12/16/1997 | US5698204 Polypeptides |
| 12/16/1997 | US5698203 Attenuated viruse reactive with monoclonal antibody a27 |
| 12/16/1997 | US5698202 Deletion of e-1 gene and replacement with cytomegalovirus promoter sequence which controls the expression of dna coding for a rabies virus protein useful in single-dose rabies vaccines, also partial deletion of e-3 gene |
| 12/16/1997 | US5698201 Method for treatment of antigenically modified polypeptides |
| 12/16/1997 | US5698196 Antibodies specific for neutrophic chemotactic factor |
| 12/16/1997 | US5698178 Binding a multidrug transporter protein and an antigen associated with a tumor or infectious agent |
| 12/16/1997 | US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent |
| 12/16/1997 | CA1339590C Peptide mixture useful for the malaria vaccine manufactrue, process for the preparation of said mixture and use thereof |
| 12/16/1997 | CA1339583C Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
| 12/16/1997 | CA1339582C Monoclonal antibodies and methods for diagnosis of phytophthora infection |
| 12/11/1997 | WO1997046710A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
| 12/11/1997 | WO1997046697A3 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046697A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046693A1 Virus-like particles useful as a vector for delivering nucleic acid |
| 12/11/1997 | WO1997046688A1 Lipid kinase |
| 12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
| 12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
| 12/11/1997 | WO1997046666A1 Modified small rna viruses |
| 12/11/1997 | WO1997046589A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/11/1997 | WO1997046588A1 Cellular internalization of pigr stalk and associated ligands |
| 12/11/1997 | WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
| 12/11/1997 | WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof |
| 12/11/1997 | WO1997046255A2 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 12/11/1997 | WO1997046253A2 Immunotherapy for autoimmune disease |
| 12/11/1997 | WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 12/11/1997 | WO1997046204A2 Injectable compositions |
| 12/11/1997 | WO1997046103A1 Modified live avian polyomavirus vaccine in psittacine birds |
| 12/11/1997 | WO1996037178A3 Novel method of enhancing efficiency of anti-arthropod agents against blood-feeding ectoparasites |
| 12/11/1997 | CA2259469A1 Injectable compositions |
| 12/11/1997 | CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 12/11/1997 | CA2257409A1 Modified live avian polyomavirus vaccine in psittacine birds |
| 12/11/1997 | CA2257389A1 Virus-like particles useful as a vector for delivering nucleic acid |
| 12/11/1997 | CA2257117A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
| 12/11/1997 | CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof |
| 12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
| 12/11/1997 | CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies |
| 12/11/1997 | CA2256304A1 Cellular internalization of pigr stalk and associated ligands |
| 12/10/1997 | EP0811846A2 Stabilisation of metal conjugates |
| 12/10/1997 | EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification |
| 12/10/1997 | EP0811688A2 Staphylococcus aureus RNase P |
| 12/10/1997 | EP0811075A1 A method for the isolation and purification of lipid cell-wall components |
| 12/10/1997 | EP0811073A2 Methods and compositions for administering gene therapy vectors |
| 12/10/1997 | EP0811071A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 12/10/1997 | EP0811067A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 12/10/1997 | EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |